Medical Termination of Pregnancy : Evaluation of Patients' Practices &

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This study evaluate the feelings of patients about a medical termination of pregnancy that they experienced in Brest Hospital. Patients responded to an online questionnaire assessing their feelings at each stage of the medical termination process. Their answers were associated with their medical data.

See also
Status	Clinical Trial	Phase
Completed	`NCT02614781` - Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea	N/A
Recruiting	`NCT02171845` - Mechanisms and Factors Responsible for the Inhibition of Transposons During Fetal Gonad Development in Humans
Completed	`NCT05202639` - Decision-making Regarding the Possibility of Medical Termination of Pregnancy

NCT number	NCT04294212
Study type	Observational
Source	University Hospital, Brest
Contact	Anne-Hélène Saliou
Phone	02-98-22-35-33
Email	anne-helene.saliou@chu-brest.fr
Status	Recruiting
Phase
Start date	February 10, 2020
Completion date	August 10, 2020

Medical Termination of Pregnancy : Evaluation of Patients' Practices and Feelings in Brest Hospital — IMGEPR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms